Carlyle buys 20% stake in Piramal Pharma businesses

This post was originally published on this site

https://i-invdn-com.akamaized.net/news/LYNXNPEC0L0PD_M.jpg

The capital increase aims to accelerate Piramal Pharma’s organic and inorganic growth plans, according to the statement.